Viewing Study NCT04578834


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-05-09 @ 3:18 PM
Study NCT ID: NCT04578834
Status: COMPLETED
Last Update Posted: 2025-12-23
First Post: 2020-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None IgA Nephropathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LNP023 View
None IgA nephropathy View
None IgAN, proteinuria View
None UPCR View
None eGFR View
None eGFR slope View
None kidney function decline View